A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial. (2018)

First Author: Smyth EC
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdy407

PubMed Identifier: 30481267

Publication URI: http://europepmc.org/abstract/MED/30481267

Type: Journal Article/Review

Volume: 29

Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology

Issue: 12

ISSN: 0923-7534